Carmen Saez (C Sáez, Carmen Sáez)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Venues

Cancers

International journal of molecular sciences

Biomedicines

Cell death discovery

Instituto de Biomedicina de Sevilla

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Instituto de Biomedicina de Sevilla Mar 01 2012

Spain

Investigadora Principal :: Oncohematología y Genética

Hospital Universitario Virgen del Rocío

Spain

Miguel Servet Contract :: Pathology

Hospital Universitario Virgen del Rocío

Spain

Postdoctoral Fellow :: Pathology

Instituto de Salud de Cataluña

Spain

Médico de atención primaria :: Atención primaria

Publications

Ines Rivero Belenchon, Carmen Belen Congregado Ruiz, Carmen Saez, Ignacio Osman-Garcia, Rafael Antonio Medina-López
Parp Inhibitors and Radiotherapy: A New Combination for Prostate Cancer (Systematic Review). International journal of molecular sciences 24 (16) (2023)
Ines Rivero Belenchon, Inés Rivero, Ignacio Osmán, Carmen Saez, Rafael Medina López
PARP Inhibitors: A New Horizon for Patients with Prostate Cancer. Biomedicines 10 (6) (2022)
Alejandro Belmonte-Fernández, Joaquín Herrero-Ruíz, María Galindo-Moreno, M Cristina Limón-Mortés, Mar Mora-Santos, Carmen Saez, Miguel Á Japón, Maria Tortolero, Francisco Romero
Cisplatin-induced cell death increases the degradation of the MRE11-RAD50-NBS1 complex through the autophagy/lysosomal pathway. Cell death and differentiation (2022)
Rocío Jiménez-Guerrero, Alejandro Belmonte-Fernández, M Luz Flores, Mónica González-Moreno, Begoña Pérez-Valderrama, Francisco Romero, Miguel A Japón, Carmen Saez
Wnt/β-Catenin Signaling Contributes to Paclitaxel Resistance in Bladder Cancer Cells with Cancer Stem Cell-Like Properties. International journal of molecular sciences 23 (1) (2021)
Jessica Gasca, M L Flores, Rocío Jiménez-Guerrero, María Eugenia Sáez, Isabel Barragán, M Ruíz-Borrego, M Tortolero, Francisco Romero, Carmen Saez, Miguel A Japón
EDIL3 promotes epithelial-mesenchymal transition and paclitaxel resistance through its interaction with integrin αVβ3 in cancer cells. Cell death discovery 6 (2020)
María Galindo-Moreno, Servando Giráldez, M Cristina Limón-Mortés, Alejandro Belmonte-Fernández, Carmen Saez, Miguel Á Japón, Maria Tortolero, Francisco Romero
p53 and FBXW7: Sometimes Two Guardians Are Worse than One. Cancers 12 (4) (2020)
Rocío Jiménez-Guerrero, Jessica Gasca, M Luz Flores, Begoña Pérez-Valderrama, Cristina Tejera-Parrado, Rafael Antonio Medina-López, María Tortolero, Francisco Romero, Miguel A Japón, Carmen Saez
Obatoclax and Paclitaxel Synergistically Induce Apoptosis and Overcome Paclitaxel Resistance in Urothelial Cancer Cells. Cancers 10 (12) (2018)

Carmen Saez.css-eqlu8i{font-size:small;padding-left:4px;} (C Sáez, Carmen Sáez)

Publication Activity (10 Years)

Top Topics

Top Venues

Carmen Saez (C Sáez, Carmen Sáez)